Abstract
Selection of T-cell vaccine antigens for chronic persistent viral infections has been largely empirical. To define the relationship, at the population level, between the specificity of the cellular immune response and viral control for a relevant human pathogen, we performed a comprehensive analysis of the 160 dominant CD8+ T-cell responses in 578 untreated HIV-infected individuals from KwaZulu-Natal, South Africa. Of the HIV proteins targeted, only Gag-specific responses were associated with lowering viremia. Env-specific and Accessory/Regulatory protein–specific responses were associated with higher viremia. Increasing breadth of Gag-specific responses was associated with decreasing viremia and increasing Env breadth with increasing viremia. Association of the specific CD8+ T-cell response with low viremia was independent of HLA type and unrelated to epitope sequence conservation. These population-based data, suggesting the existence of both effective immune responses and responses lacking demonstrable biological impact in chronic HIV infection, are of relevance to HIV vaccine design and evaluation.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Nucleocapsid-specific T cell responses associate with control of SARS-CoV-2 in the upper airways before seroconversion
Nature Communications Open Access 24 May 2023
-
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity
Nature Communications Open Access 29 October 2022
-
A longitudinal analysis of immune escapes from HLA-B*13-restricted T-cell responses at early stage of CRF01_AE subtype HIV-1 infection and implications for vaccine design
BMC Immunology Open Access 02 April 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout






References
Burton, D.R. et al. HIV vaccine design and the neutralising antibody problem. Nat. Immunol. 5, 233–236 (2004).
Goulder, P.J. & Watkins, D.I. HIV and SIV CTL escape: implications for vaccine design. Nat. Rev. Immunol. 4, 630–640 (2004).
Draenert, R. et al. Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection. J. Virol. 78, 630–641 (2004).
Addo, M.M. et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 77, 2081–2092 (2003).
Kiepiela, P. et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432, 769–775 (2004).
Leslie, A.J. et al. HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med. 10, 282–289 (2004).
Friedrich, T.C. et al. Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nat. Med. 10, 275–281 (2004).
Matano, T. et al. Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial. J. Exp. Med. 199, 1709–1718 (2004).
Kobayashi, M. et al. Reversion in vivo after inoculation of a molecular proviral DNA clone of simian immunodeficiency virus with a cytotoxic-T-lymphocyte escape mutation. J. Virol. 79, 11529–11532 (2005).
Fernandez, C.S. et al. Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost. J. Virol. 79, 5721–5731 (2005).
Martinez-Picado, J. et al. Fitness cost of escape mutation in p24 Gag in association with control of HIV-1. J. Virol. 80, 3617–3623 (2006).
Leslie, A. et al. Transmission and accumulation of CTL escape variants drives negative associations between HIV polymorphisms and HLA. J. Exp. Med. 201, 891–902 (2005).
Mellors, J.W. et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272, 1167–1170 (1996).
Lyles, R.H. et al. Natural history of HIV-1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. J Infect. Dis. 181, 872–880 (2000).
Goulder, P.J. et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 3, 212–217 (1997).
Feeney, M.E. et al. Immune escape precedes breakthrough HIV-1 viremia and broadening of the CTL response in a HLA-B27-positive long-term nonprogressing child. J. Virol. 78, 8927–8930 (2004).
Wilson, J.D. et al. Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection. AIDS 14, 225–233 (2000).
Barouch, D.H. et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 415, 335–339 (2002).
Allen, T.M. et al. Tat-specific CTL select for SIV escape variants during resolution of primary viremia. Nature 407, 386–390 (2000).
Migueles, S.A. et al. The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences. J. Virol. 77, 6889–6898 (2003).
Riviere, Y. et al. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS. AIDS Res. Hum. Retroviruses 11, 903–907 (1995).
Klein, M.R. et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181, 1365–1372 (1995).
Ogg, G.S. et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279, 2103–2106 (1998).
Edwards, B.H. et al. Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J. Virol. 76, 2298–2305 (2002).
Novitsky, V. et al. Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection. J Virol. 77, 882–890 (2003).
Masemola, A. et al. Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load. J. Virol. 78, 3233–3243 (2004).
Ramduth, D. et al. Differential immunogenicity of HIV-1 clade C proteins in eliciting CD8+ and CD4+ cell responses. J. Infect. Dis. 192, 1588–1596 (2005).
Zuniga, R. et al. Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control. J. Virol. 80, 3122–3125 (2006).
Musey, L. et al. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N. Engl. J. Med. 337, 1267–1274 (1997).
Borrow, P. et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 3, 205–211 (1997).
Safrit, J.T. et al. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope. J. Exp. Med. 179, 463–472 (1994).
Safrit, J.T. et al. A region of the third variable loop of HIV-1 gp120 is recognized by HLA-B7-restricted CTLs from two acute seroconversion patients. J. Immunol. 153, 3822–3830 (1994).
Price, D.A. et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc. Natl. Acad. Sci. USA 94, 1890–1895 (1997).
Betts, M.R. et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4+ and CD8+ T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75, 11983–11991 (2001).
Frahm, N. et al. Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J. Virol. 78, 2187–2200 (2004).
Briggs, J.A. et al. The stoichiometry of Gag protein in HIV-1. Nat. Struct. Mol. Biol. 11, 672–675 (2004).
Gallimore, A. et al. Early suppression of SIV replication by CD8+ Nef-specific cytotoxic T cells in vaccinated macaques. Nat. Med. 1, 1167–1173 (1995).
Hel, Z. et al. Improved protection from simian AIDS by the addition of non-structural SIV genes. J. Immunol. 176, 85–96 (2006).
Casimiro, D.R. et al. Attenuation of SIVmac239 by prophylactic immunization with DNA and recombinant adenoviral vectors expressing Gag. J. Virol. 79, 15547–15555 (2005).
Wilson, N.A. et al. Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic SIVmac239. J. Virol. 80, 5875–5885 (2006).
Staprans, S.I. et al. Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to SIV envelope protein. Proc. Natl. Acad. Sci. USA 101, 13026–13031 (2004).
Reimann, K.A. et al. Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses. J. Virol. 79, 8878–8888 (2005).
Goulder, P.J. et al. Rapid definition of five novel HLA-A*3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by elispot and intracellular cytokine staining assays. J. Virol. 75, 1339–1347 (2001).
Rousseau, C.M. et al. Method for high-throughput amplification, cloning and sequencing of full-length HIV-1 subtype C genomes. J. Virol. Methods 136, 118–125 (2006).
Moore, C.B. et al. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296, 1439–1443 (2002).
Storey, J.D. & Tibshirani, R. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. USA 100, 9440–9445 (2003).
Thompson, J.D., Higgins, D.G. & Gibson, T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22, 4673–4680 (1994).
Maddison, W.P. & Maddison, D.R. Interactive analysis of phylogeny and character evolution using the computer program MacClade. Folia Primatol. (Basel) 53, 190–202 (1989).
Acknowledgements
This work is funded by the US National Institutes of Health (contract NO1-A1-15422, 2RO1AI46995-06 and R01AI067073), the Wellcome Trust (A.L. and P.G.), and the Mark and Lisa Schwartz Foundation. B.D.W. is a Doris Duke Distinguished Clinical Science Professor. P.G. is an Elizabeth Glaser Pediatric AIDS Foundation Scientist.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Fig. 1
Viral loads (showing median values) of responders and non-responders expressing the relevant restricting HLA class I allele to the 160 identified CD8+ T cell responses. (PDF 928 kb)
Supplementary Fig. 2
Average entropy of the 18mer peptides within each protein (showing interquartile ranges and medians). (PDF 2467 kb)
Supplementary Fig. 3
Phenotypic frequencies of the HLA class I alleles present at >0.5% in the total study cohort (n=578), compared with phenotypic frequencies of the 272 subjects whose full-length viral sequences were determined. (PDF 1083 kb)
Supplementary Table 1
18mer peptides identified as the dominant epitopes targeted in this cohort, with the HLA class I restriction shown and, where defined, the optimal epitope within the 18mer peptide. (PDF 1085 kb)
Supplementary Table 2
Correlation in number of CD8+ T cell responses to each protein, and regression coefficients from linear regression of viral load on number of responses. (PDF 513 kb)
Supplementary Table 3
Number of epitopes containing polymorphisms associated with expression of the HLA class I molecule that was restricting the response. (PDF 1638 kb)
Rights and permissions
About this article
Cite this article
Kiepiela, P., Ngumbela, K., Thobakgale, C. et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 13, 46–53 (2007). https://doi.org/10.1038/nm1520
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1520
This article is cited by
-
Nucleocapsid-specific T cell responses associate with control of SARS-CoV-2 in the upper airways before seroconversion
Nature Communications (2023)
-
Deep sequencing of the HIV-1 polymerase gene for characterisation of cytotoxic T-lymphocyte epitopes during early and chronic disease stages
Virology Journal (2022)
-
A longitudinal analysis of immune escapes from HLA-B*13-restricted T-cell responses at early stage of CRF01_AE subtype HIV-1 infection and implications for vaccine design
BMC Immunology (2022)
-
Immunoescape of HIV-1 in Env-EL9 CD8 + T cell response restricted by HLA-B*14:02 in a Non progressor who lost twenty-seven years of HIV-1 control
Retrovirology (2022)
-
Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound
Scientific Reports (2022)